Sionna therapeutics, inc.SION.US Overview

US StockHealthcare

(No presentation for SION)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

SION Overall Performance

SION AI Analysis & Strategy

SION Recent Performance

6.75%

Sionna therapeutics, inc.

0.81%

Avg of Sector

-1.14%

S&P500

SION PowerScanner

SION Key Information

SION Valuation Metrics

SION Earnings Table

SION Profile

Sionna Therapeutics, Inc. is a biopharmaceutical company. The Company provides treatment paradigm for cystic fibrosis patients by developing medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator.